CBD (cannabidiol)
Evidence: weak
No study directly shows that CBD improves performance or recovery in athletes. The claims rest on animal work and small trials in non-athletes. The market is poorly regulated, most products are mislabelled, and about a fifth contain THC, enough to fail a drug test in a product sold as non-intoxicating.
Not medical advice
This is a general knowledge base, not medical or dietary advice. If you are injured, unwell or weighing up a supplement, speak to a doctor or registered dietitian who knows your situation. If you compete under anti-doping rules, check current guidance before using any cannabinoid product.
Keep it in proportion
The basics are where the real gains are: consistent volume, sleep and adequate fuelling. Weigh anything below honestly, and do not let a marginal or over-marketed product pull attention from the things that actually move the needle.
Cannabidiol (CBD) is a non-intoxicating compound from the cannabis plant, distinct from THC, the compound that produces a high. It is sold to runners in oils, capsules, balms and drinks, marketed for recovery, sleep, pain, inflammation and anxiety. The marketing runs well ahead of the evidence.
What the evidence actually shows
A narrative review of CBD and sports performance reached a blunt conclusion: studies directly investigating CBD in athletes are lacking, and there is no direct evidence that it improves performance or recovery (McCartney et al. 2020). The mechanisms people hope for, among them less anxiety, better sleep, pain relief, an anti-inflammatory effect and protection of the gut lining, rest largely on studies in laboratory animals and a handful of trials in non-athletes, and the authors describe the human evidence as preliminary and at times inconsistent. The anti-inflammatory and pain-relieving effects that look convincing in animals are limited and inconclusive in people, and the sleep benefit rests mostly on case reports. None of this means CBD does nothing; it means that, for a runner, the benefits are unproven rather than established.
The market is poorly regulated
Product quality is a genuine problem in its own right. When researchers bought 84 CBD products online and tested them, only about 31% were labelled accurately for CBD content, some holding far more than stated and some far less. More seriously, THC turned up in around 21% of them (Bonn-Miller et al. 2017). In a product sold as non-intoxicating, undeclared THC can produce an unexpected effect and, for a tested athlete, a failed drug test. This is the supplement contamination problem in a particularly unregulated corner of the market.
Anti-doping status
The status is narrow and easy to get wrong. The World Anti-Doping Agency removed CBD from its Prohibited List with effect from 1 January 2018, so CBD itself is permitted in and out of competition. It is the sole exception (WADA and USADA guidance). Every other cannabinoid, natural or synthetic, including THC, remains prohibited in competition. Because CBD products are so often contaminated with THC, a runner using CBD can still test positive, and for anyone in a testing pool that risk is the decisive point.
The honest take
CBD is early-stage and, for running, unproven. Anyone who chooses to try it, most plausibly for sleep or anxiety rather than performance, needs a third-party-tested product to manage the contamination and doping risk, and competitive athletes should weigh whether it is worth any risk at all given the absence of demonstrated benefit. It belongs with the supplements that do not hold up until real evidence in athletes arrives; for sleep, the basics of sleep do far more.